<p>Paraffin sections of the tibial metaphysis region (PS = Primary spongiosa, SS = Secondary spongiosa, which are separated by a dashed line) of (<b>A</b>) a normal rat, (<b>B</b>) a MTX+H<sub>2</sub>O treated rat showing reduced height of primary spongiosa and. metaphyseal bone volume, (<b>C</b>) a MTX+FO treated rat, and (<b>D</b>) a MTX+Gen treated rat. (<b>E</b>) Growth plate total height (µm). (<b>F</b>) Primary spongiosa height (µm). (<b>G</b>) Secondary spongiosa BV/TV (%). (<b>H</b>) Secondary spongiosa osteoblast/mm<sup>2</sup> trabecular bone area. Values are means ± SEM; n = 7–8 for all groups. Labelled means without a common letter differ (P<0.05).</p
<p>Representative micrographs of PTM from basal (BAS), vehicle (aging) control (CON), prednisone (GC...
Intensive cancer chemotherapy is known to cause bone defects, which currently lack treatments. This ...
Aim: To establish the effect of three single chemotherapeutic agents on the growing skeleton, male W...
<p>H&E alcian staining of metaphyseal bone in control (A), MTX-treated (B) and MTX+FA (C) treated ra...
<p>Images of TRAP-stained tibial metaphysis (arrows pointing multinucleated TRAP-positive osteoclast...
<p>H&E staining of rat tibia from control (A), MTX-treated (B) and MTX+FA treated rats (C) at week 6...
<p>TRAP-stained sections of tibia from a control (A), MTX-treated (B), and a MTX+FA treated rat (C),...
<p>H&E-stained sections of a tibia from a control (A), MTX-treated (B) and a MTX+FA (C) treated rat,...
Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis an...
Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis an...
<p>Levels of mRNA expression in metaphysis bones of treated rats as quantitated by real time RT-PCR:...
Methotrexate (MTX) chemotherapy is known to cause bone loss which lacks specific preventative treatm...
<p>H&E-stained sections of tibia from a control (A), MTX-treated (B) and MTX+FA treated rat (C). Tre...
Methotrexate (MTX) is a most commonly used anti-metabolite in cancer treatment and as an anti-rheuma...
<p>(A) Representative images showing the distance between the metaphyseal end of the growth cartilag...
<p>Representative micrographs of PTM from basal (BAS), vehicle (aging) control (CON), prednisone (GC...
Intensive cancer chemotherapy is known to cause bone defects, which currently lack treatments. This ...
Aim: To establish the effect of three single chemotherapeutic agents on the growing skeleton, male W...
<p>H&E alcian staining of metaphyseal bone in control (A), MTX-treated (B) and MTX+FA (C) treated ra...
<p>Images of TRAP-stained tibial metaphysis (arrows pointing multinucleated TRAP-positive osteoclast...
<p>H&E staining of rat tibia from control (A), MTX-treated (B) and MTX+FA treated rats (C) at week 6...
<p>TRAP-stained sections of tibia from a control (A), MTX-treated (B), and a MTX+FA treated rat (C),...
<p>H&E-stained sections of a tibia from a control (A), MTX-treated (B) and a MTX+FA (C) treated rat,...
Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis an...
Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis an...
<p>Levels of mRNA expression in metaphysis bones of treated rats as quantitated by real time RT-PCR:...
Methotrexate (MTX) chemotherapy is known to cause bone loss which lacks specific preventative treatm...
<p>H&E-stained sections of tibia from a control (A), MTX-treated (B) and MTX+FA treated rat (C). Tre...
Methotrexate (MTX) is a most commonly used anti-metabolite in cancer treatment and as an anti-rheuma...
<p>(A) Representative images showing the distance between the metaphyseal end of the growth cartilag...
<p>Representative micrographs of PTM from basal (BAS), vehicle (aging) control (CON), prednisone (GC...
Intensive cancer chemotherapy is known to cause bone defects, which currently lack treatments. This ...
Aim: To establish the effect of three single chemotherapeutic agents on the growing skeleton, male W...